Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
86.73 USD | +0.22% |
|
-4.42% | -13.84% |
09:43am | Guggenheim Adjusts Price Target on Merck & Co. to $115 From $122 | MT |
02-11 | HSBC Adjusts Price Target on Merck to $115 From $130 | MT |
Evolution of the Average Target: Merck & Co., Inc.
Evolution of the Target Price: Merck & Co., Inc.
Changes in Analyst Recommendations: Merck & Co., Inc.
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+34.82% | ||||||
+13.28% | ||||||
+8.01% | ||||||
+37.7% | ||||||
+6.81% | ||||||
+6.64% | ||||||
+20.92% | ||||||
+6.71% | ||||||
+6.75% | ||||||
+22.11% | ||||||
Average | +16.38% | |||||
Weighted average by Cap. | +16.02% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
HSBC | |
Bernstein | |
TD Cowen | |
UBS | |
JPMorgan Chase | |
Leerink Partners | |
Goldman Sachs | |
Daiwa Securities | |
Jefferies & Co. | |
Citigroup | |
Wells Fargo Securities | |
Deutsche Bank Securities | |
Morgan Stanley | |
Guggenheim | |
Truist Securities | |
BMO Capital | |
Berenberg Bank | |
CFRA | |
Argus | |
Barclays | |
Redburn Atlantic | |
Wolfe Research | |
Cantor Fitzgerald | |
Zacks Investment Research | |
Societe Generale | |
BofA Securities | |
Atlantic Equities | |
Credit Suisse | |
SVB Securities LLC | |
Cowen | |
SVB Leerink | |
RBC Capital Markets | |
RBC | Randall Stanicky |
JPMORGAN |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Consensus Merck & Co., Inc.

MarketScreener is also available in this country: United States.
Switch edition